Did you know? | Study links obesity, BMI to gastrointestinal symptoms | Diagnosed with IBS? Know your treatment options
April 25, 2012
CONNECT WITH ACG®  FacebookTwitter
Digestive Health SmartBrief
From American College of Gastroenterology

Did you know?
Did you know?
Fiber is a substance in plants. Dietary fiber is the kind you eat. It is in fruits, vegetables and grains. It is the part of the plant that your body can't digest. Yet it is an important part of a healthy diet. ... You can get fiber from whole grains, beans, nuts, fruits and vegetables. You should add fiber to your diet slowly. -- MedlinePlus
Share: LinkedInTwitterFacebookGoogle+Email
Top Story
Study links obesity, BMI to gastrointestinal symptoms
An analysis of 21 studies links certain gastrointestinal symptoms, such as gastroesophageal reflux and diarrhea, with higher body mass index and obesity. Australian researchers said obese patients were almost three times as likely to have upper abdominal pain, but the analysis found no association between obesity and lower abdominal pain, bloating, constipation, nausea, fecal incontinence or anal blockage. Medscape (free registration) (4/19)
Share: LinkedInTwitterFacebookGoogle+Email
Guide to Healthy Living
Diagnosed with IBS? Know your treatment options
The American College of Gastroenterology evaluated a broad spectrum of medical research and conducted a rigorous review of the evidence regarding the effectiveness of testing and treatments for IBS. The results were graded by physician experts based on the quality of the scientific studies, including study design and findings and published in The American Journal of Gastroenterology in January 2009. The IBS Treatment Matrix provides an at-a-glance overview of all currently available IBS treatment options, plus evidence supporting the safety and efficacy of those options, enabling you and your physician to consider all the possible alternatives while formulating a treatment plan. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Fatty liver disease is common, preventable, experts say
The once minor problem of nonalcoholic fatty liver disease has become the world's most common cause of chronic liver illness and may affect 30% of Americans, says Dr. Kathleen Corey, director of Massachusetts General Hospital's Fatty Liver Clinic. Linked to obesity and diabetes, experts say most people do not know they have fatty liver but it can lead to liver inflammation, cirrhosis, cancer or the need for a transplant. Chicago Tribune (tiered subscription model) (4/18)
Share: LinkedInTwitterFacebookGoogle+Email
Report: Healthier lifestyles are needed to lower disease rates
The rates of cancer and other chronic diseases could be lowered through healthier diets, exercise, weight loss, preventive screenings and reducing tobacco use, according to the American Cancer Society's annual "Cancer Prevention & Early Detection Facts & Figures" report. The report says an estimated 577,000 people will die from cancer this year, with one-third of the cases caused by obesity, poor nutrition and a lack of exercise. The authors called for more collaboration among government, private industry, nonprofits and health care providers to reduce disease risks. MedPage Today (free registration) (4/19)
Share: LinkedInTwitterFacebookGoogle+Email
Poll highlights indicators of rotavirus vaccination in U.S. children
Data from the 2009 National Immunization Survey showed that children without health insurance were 12% more likely not to receive the rotavirus vaccine than insured children. Researchers also found that children with a parent who did not graduate from college had a 21% greater chance of not getting the vaccine compared with those with a parent who did graduate from college. Family Practice News (4/19)
Share: LinkedInTwitterFacebookGoogle+Email
Diagnosis & Treatment
Study recommends vitamin D dosages for children with IBD
Children and adolescents with inflammatory bowel disease who need large dosages of vitamin D did better taking 2,000 international units of vitamin D3 daily for six weeks or a 50,000-IU dose of vitamin D2 weekly, rather than 2,000 IU of vitamin D2 per day, according to a Children's Hospital Boston study. Low vitamin D is common in children with IBD, researchers said. Medscape (free registration)/Reuters (4/17)
Share: LinkedInTwitterFacebookGoogle+Email
Physician: Gut microbiome science still in its infancy
The science behind changing microbial gut flora is in early stages but potentially could prevent or lead to treatments for gastrointestinal disorders and even obesity, says Dr. Walter Coyle of the Scripps Clinic in California. He told a physician conference that people are not waiting for the science, however, and are using probiotics, prebiotics and fecal transplants to alter the gut microbiome to reduce GI symptoms. MedPage Today (free registration) (4/22)
Share: LinkedInTwitterFacebookGoogle+Email
Hepatitis C drug candidates yield positive results in trials
All hepatitis C patients treated with Gilead Sciences' GS-7977 plus Bristol-Myers Squibb's daclatasvir attained a sustained virologic response four weeks after the treatment, a clinical trial found. In another study, 88% of 25 treatment-naive patients with genotype 1 hepatitis C who received Gilead's GS-7977 and ribavirin achieved SVR 4 after 12 weeks of treatment. The results boost the possibilities for an interferon-free, all-oral regimen for hepatitis C. The Wall Street Journal (tiered subscription model)/Dow Jones Newswires (4/19)
Share: LinkedInTwitterFacebookGoogle+Email
Cancer patients seldom report care problems, survey shows
Few cancer patients reported problems with their doctor or nurse, whether communication-related or medical, according to a study in the Journal of Clinical Oncology. Researchers conducted a telephone interview with 416 patients with breast or colon cancer and found that 93 of them said they experienced a preventable or harmful event. Of the patients who completed interviews, a third said they spoke with their care provider about the problem, and 10 reported it to hospital administrators. DoctorsLounge.com/HealthDay News (4/18), Reuters (4/18)
Share: LinkedInTwitterFacebookGoogle+Email
Clinical Trial Monitor
A selection of U.S. based clinical trials seeking participants
Comparison of the Efficacy of a Biological Implant to Reinforce Overlapping Sphincter Repair Versus Overlapping Sphincter Repair Alone
Ohio. clinicaltrials.gov
Share: LinkedInTwitterFacebookGoogle+Email
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Michigan. clinicaltrials.gov
Share: LinkedInTwitterFacebookGoogle+Email
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
Missouri. clinicaltrials.gov
Share: LinkedInTwitterFacebookGoogle+Email
Racial Disparity in Barrett's Esophagus
North Carolina. clinicaltrials.gov
Share: LinkedInTwitterFacebookGoogle+Email
Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer
Georgia, Pennsylvania, South Carolina, Tennessee. clinicaltrials.gov
Share: LinkedInTwitterFacebookGoogle+Email
The Last Word
News and information from the American College of Gastroenterology
Take the itch and burn out of hemorrhoids -- Tips to reduce pain and discomfort
Are you tired of the itch and burn of hemorrhoids? While it's a fairly common condition, many patients may be too embarrassed to talk to their doctor about it. The ACG has tips to reduce the pain and discomfort of hemorrhoids.
Share: LinkedInTwitterFacebookGoogle+Email
Press Releases
Post a Press Release
One way to keep momentum going is to have constantly greater goals.
Michael Korda,
British-American writer
Share: LinkedInTwitterFacebookGoogle+Email
Contact Your Doctor
American College of Gastroenterology
Contact ACG
American College of Gastroenterology
P.O. Box 342260
Bethesda, MD 20827-2260
The presence of any advertisement in this newsletter does not constitute endorsement of the associated service, product, or company by the American College of Gastroenterology, SmartBrief, or any participating physicians.
The information contained in Digestive Health SmartBrief is not intended to be medical advice. Consult your physician before making any decisions regarding your health care.
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information